EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Long‐Term Blood Pressure Variability in Cerebral Amyloid Angiopathy is Associated with Ischemic Brain Injury and Cognitive Decline

Lukas Sveikata iD, Maria Clara Zanon Zotin iD, Dorothee Schoemaker iD, Yuan Ma iD, Valentina Perosa iD, Anthipa Chokesuwattanaskul iD, Andreas Charidimou iD, Marco Duering iD, M Edip Gurol iD, Frédéric Assal iD, Steven M Greenberg iD, Anand Viswanathan iD

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.124.039087 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Lukas Sveikata und 11 weiteren Autor:innen. Beteiligte Einrichtung: J. Philip Kistler Stroke Research Center, Department of Neurology Massachusetts General Hospital, Harvard Medical School Boston MA USA. Hauptthemen laut MEDLINE: Blood Pressure, Cognitive Dysfunction, Cerebral Amyloid Angiopathy, Brain Ischemia. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long‐term blood pressure variability (BPV) has been proposed as a potential risk factor for dementia and cerebral small vessel disease progression. In this study, we investigate the association between BPV, brain injury, and cognitive decline in probable cerebral amyloid angiopathy (CAA).

Methods

Using a prospective memory clinic cohort, we enrolled 102 participants, including 52 with probable CAA and mild cognitive symptoms. BPV was assessed using a coefficient of variation derived from outpatient BP measurements (median 12) over 5 years before imaging with 3‐tesla research magnetic resonance imaging. We measured peak width of skeletonized mean diffusivity and neuroimaging markers of CAA, including lacunes and cortical cerebral microinfarcts. Using regression models, we evaluated the association of BPV with white matter integrity and whether CAA modified this association. We also examined the association of BPV with longitudinal cognitive decline.

Results

Systolic BPV had a dose‐dependent association with peak width of skeletonized mean diffusivity (standardized β=0.22, 95% CI: 0.06–0.39, P =0.010), independent of age, sex, mean BP, common vascular risk factors, brain atrophy, and CAA severity. The presence of probable CAA strengthened the association between BPV and peak width of skeletonized mean diffusivity (β=9.33, 95% CI: 1.32–17.34, P for interaction=0.023). Higher BPV correlated with the presence of lobar lacunes, cortical cerebral microinfarcts, and a decline in global cognition and processing speed.

Conclusions

Long‐term BPV had a dose‐dependent association with altered white matter integrity, ischemic brain injury, and cognitive decline. Controlling BPV might be a potential novel therapeutic target to prevent cognitive decline in memory clinic patients with probable CAA and mild cognitive symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PressureCognitive DysfunctionCerebral Amyloid AngiopathyBrain IschemiaWhite MatterHumansProspective StudiesNeuropsychological TestsNeuroimagingMagnetic Resonance ImagingMaleFemaleAgedAged, 80 and overTime Factors

Stichwörter der Autor:innen

cerebral amyloid angiopathycognitive impairmenthypertensionmemory clinicstroke

Autor:innen und Institutionen

  • J. Philip Kistler Stroke Research Center, Department of Neurology Massachusetts General Hospital, Harvard Medical School Boston MA USA.
  • Division of Neurology, Department of Clinical Neurosciences Geneva University Hospital and University of Geneva Geneva Switzerland.
  • Department of Medical Imaging, Hematology and Clinical Oncology, Center for Imaging Sciences and Medical Physics Ribeirão Preto Medical School, University of São Paulo Ribeirão Preto SP Brazil.
  • Department of Epidemiology Harvard T.H. Chan School of Public Health Boston MA USA.
  • Cognitive Clinical and Computational Neuroscience Research Unit, Faculty of Medicine Chulalongkorn University Bangkok Thailand.
  • Institute for Stroke and Dementia Research (ISD) LMU University Hospital, LMU Munich Munich Germany.

ORCID-Profile: Lukas Sveikata, Maria Clara Zanon Zotin, Dorothee Schoemaker, Yuan Ma, Valentina Perosa, Anthipa Chokesuwattanaskul, Andreas Charidimou, Marco Duering, M Edip Gurol, Frédéric Assal, Steven M Greenberg, Anand Viswanathan

Förderung

  • NINDS NIH HHS

Zitieren

APA

Sveikata, L., Zanon Zotin, M. C., Schoemaker, D., Ma, Y., Perosa, V., Chokesuwattanaskul, A., Charidimou, A., Duering, M., Gurol, M. E., Assal, F., Greenberg, S. M., & Viswanathan, A. (2026). Long‐Term Blood Pressure Variability in Cerebral Amyloid Angiopathy is Associated with Ischemic Brain Injury and Cognitive Decline. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.039087

Vancouver

Sveikata L, Zanon Zotin MC, Schoemaker D, Ma Y, Perosa V, Chokesuwattanaskul A, et al. Long‐Term Blood Pressure Variability in Cerebral Amyloid Angiopathy is Associated with Ischemic Brain Injury and Cognitive Decline. Journal of the American Heart Association. 2026. doi:10.1161/jaha.124.039087

BibTeX
@article{Sveikata2026,
  author = {Sveikata, Lukas and Zanon Zotin, Maria Clara and Schoemaker, Dorothee and Ma, Yuan and Perosa, Valentina and Chokesuwattanaskul, Anthipa and Charidimou, Andreas and Duering, Marco and Gurol, M Edip and Assal, Frédéric and Greenberg, Steven M and Viswanathan, Anand},
  title = {Long‐Term Blood Pressure Variability in Cerebral Amyloid Angiopathy is Associated with Ischemic Brain Injury and Cognitive Decline},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.124.039087}
}
Kostenlos starten →